Legal entity
All 1 tracked stories fall under one category: regulation. Of the tracked stories, 1 of 1 also mention Eli Lilly and Company, the most common co-covered peer. Source depth averages 23 original sources per story, versus 3.3 across the same-window beat baseline.
Last mentioned: Mar 23, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: regulation. Of the tracked stories, 1 of 1 also mention Eli Lilly and Company, the most common co-covered peer. Source depth averages 23 original sources per story, versus 3.3 across the same-window beat baseline. At 7, the average consequence score sits above the same-window beat average of 6.4. tirzepatide appears in 1 tracked Legal story from March 13, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 42 Legal stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering tirzepatide. Shared-story counts are live from our verified record — not editorial picks.
Impurity Warning
Lilly issues formal warning after testing reveals impurities in compounded samples.
Compounding Surge
Shortage status triggers Section 503B exemptions, allowing pharmacies to mass-produce compounded versions.
Zepbound Approval
Tirzepatide approved for chronic weight management, exacerbating supply shortages.
Mounjaro FDA Approval
FDA approves tirzepatide for type 2 diabetes, leading to immediate high demand.
Eli Lilly has issued a formal warning regarding discovered impurities in compounded versions of its blockbuster weight-loss medication, tirzepatide. This development marks a significant escalation in the ongoing regulatory and legal conflict between pharmaceutical giants and the compounding industry over safety standards and patent enforcement.
Source: kiss1067.iheart.com · power1051.iheart.com
tirzepatide is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
